Loading publications…
The last 5 uploaded publications
The features and management of acquired resistance to PD1-based therapy in metastatic melanoma
Adriana Hepner, Judith M. Versluis, Roslyn Wallace, Clara Allayous, Lauren Brown, Claudia Trojaniello, Camille L. Gérard, Yanina JL Jansen, Prachi Bhave, Bart Neyns, Andrew Haydon, Olivier Michielin, Joanna Mangana, Oliver Klein, Alexander N. Shoushtari, Allison Betof Warner, Paolo A. Ascierto, Jennifer L. McQuade, Matteo S. Carlino, Lisa Zimmer, Célèste Lebbé, Douglas B. Johnson, Shahneen Sandhu, Victoria Atkinson, Christian U. Blank, Serigne Lo, Georgina V. Long, Alexander M. Menzies (2023). The features and management of acquired resistance to PD1-based therapy in metastatic melanoma. , 196, DOI: https://doi.org/10.1016/j.ejca.2023.113441.
Article62 days agoUtomilumab in Patients With Immune Checkpoint Inhibitor-Refractory Melanoma and Non-Small-Cell Lung Cancer
David S. Hong, Ajay K. Gopal, Alexander N. Shoushtari, Sandip Pravin Patel, Aiwu Ruth He, Toshihiko Doi, Suresh S. Ramalingam, Amita Patnaik, Shahneen Sandhu, Ying Chen, Craig B. Davis, Timothy S. Fisher, Bo Huang, Kolette D. Fly, Antoni Ribas (2022). Utomilumab in Patients With Immune Checkpoint Inhibitor-Refractory Melanoma and Non-Small-Cell Lung Cancer. , 13, DOI: https://doi.org/10.3389/fimmu.2022.897991.
Article62 days agoSingle-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study
Florentia Dimitriou, Kenjiro Namikawa, Irene L. M. Reijers, Elizabeth I. Buchbinder, J. Soon, Anne Zaremba, Paweł Teterycz, Meghan J. Mooradian, Emma Armstrong, Yasuhiro Nakamura, Maria Grazia Vitale, Lena Tran, Xue Bai, Clara Allayous, S. Provent-Roy, Alice Indini, Prachi Bhave, Mohamad Farid, Katharina C. Kähler, Inderjit Mehmi, Victoria Atkinson, Oliver Klein, Connor J. Stonesifer, Farzana Y. Zaman, Andrew Haydon, Richard D. Carvajal, Omid Hamid, Reinhard Dummer, Axel Hauschild, Matteo S. Carlino, Mario Mandalà, Caroline Robert, Célèste Lebbé, Jun Guo, Douglas B. Johnson, Paolo A. Ascierto, Alexander N. Shoushtari, Ryan J. Sullivan, Bożena Cybulska-Stopa, Piotr Rutkowski, Lisa Zimmer, Shahneen Sandhu, Christian U. Blank, Serigne Lo, Alexander M. Menzies, Georgina V. Long (2022). Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study. , 33(9), DOI: https://doi.org/10.1016/j.annonc.2022.06.004.
Article62 days agoManagement of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy☆
C. Owen, Alexander N. Shoushtari, D Chauhan, David Palmieri, Belinda Lee, Maartje W. Rohaan, Joanna Mangana, Victoria Atkinson, Farzana Y. Zaman, Arissa Young, Christoph Höeller, Peter Hersey, R. Dummer, Muhammad A. Khattak, Michael Millward, Sapna P. Patel, Andrew Haydon, Douglas B. Johnson, Serigne Lo, Christian U. Blank, Shahneen Sandhu, Matteo S. Carlino, James Larkin, Alexander M. Menzies, Georgina V. Long (2020). Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy☆. , 31(8), DOI: https://doi.org/10.1016/j.annonc.2020.04.471.
Article62 days agoNeoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
Donald A. Berry, Matthew S. Block, Genevieve M. Boland, Kathryn Bollin, Matteo S. Carlino, Richard D. Carvajal, Jonathan Cohen, Diwakar Davar, Keith A. Delman, Reinhard Dummer, Michael D. Farwell, David E. Fisher, Alberto Fusi, Isabella C. Glitza, Tanja D. de Gruijl, David Gyorki, Axel Hauschild, Tina J. Hieken, James Larkin, David H. Lawson, Célèste Lebbé, Jeffrey E. Lee, Michael Lowe, Jason J. Luke, Grant A. McArthur, David F. McDermott, Jennifer L. McQuade, Tara C. Mitchell, Teresa M. Petrella, Peter A. Prieto, Igor Puzanov, Caroline Robert, April K.S. Salama, Shahneen Sandhu, Dirk Schadendorf, Alexander N. Shoushtari, Jeffrey A. Sosman, Susan M. Swetter, Ken K Tanabe, Samra Turajlic, Douglas S. Tyler, Scott E. Woodman, Frances C. Wright, Jonathan S. Zager, Rodabe N. Amaria, Alexander M. Menzies, Elizabeth M. Burton, Richard A. Scolyer, Michael T. Tetzlaff, Robert Antdbacka, Charlotte E. Ariyan, Roland L. Bassett, Brett Carter, Adil Daud, Mark B. Faries, Leslie A. Fecher, Keith T. Flaherty, Jeffrey E. Gershenwald, Omid Hamid, Angela Hong, John M. Kirkwood, Serigne Lo, Kim Margolin, Jane L. Messina, Michael A. Postow, Helen Rizos, Merrick I. Ross, Elisa A. Rozeman, Robyn P.M. Saw, Vernon K. Sondak, Ryan J. Sullivan, Janis M. Taube, John F. Thompson, Bart A. van de Wiel, Alexander M.M. Eggermont, Michael A. Davies, Paolo A. Ascierto, Andrew J. Spillane, Alexander C.J. van Akkooi, Jennifer A. Wargo, Christian U. Blank, Hussein A. Tawbi, Georgina V. Long, Miles C. Andrews (2019). Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium. , 20(7), DOI: https://doi.org/10.1016/s1470-2045(19)30332-8.
Article62 days ago